Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of β-lactams in a mouse sepsis model

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1340-1344

  Casal, J ^a   Aguilar, L ^a   Jado, I ^a   Yuste, J ^a   Gimenez M J ^a   Prieto, J ^a   Fenoll, A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; HYPERIMMUNE GLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DILUTION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; EXPERIMENTAL MODEL; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

AMOXICILLIN; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BETA-LACTAMS; CEFOTAXIME; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SERA; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0036236859     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1340-1344.2002     Document Type: Article

References (19)

1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
2. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
3. Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model
4. Complement
5. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996)
6. Streptococcus pneumoniae in children in Spain: 1990-1999
7. Effects of low concentrations of antibiotics on bacterial ultrastructure, virulence, and susceptibility, to immunodefenses: Clinical significance
8. Intracellular and extracellular killing of a penicillin-resistant, serotype-9 strain of Streptococcus pneumoniae by polymorphonuclear leucocytes in the presence of sub-inhibitory concentrations of clavulanic acid
9. Effect of polymorphonuclear neutrophils on serum bactericidal activity against Streptococcus pneumoniae after amoxicillin administration
10. Antibodies
11. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae
12. Passive immunity in prevention and treatment of infectio.us diseases
13. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics
14. Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae
15. Streptococcus pneumoniae
16. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona
17. In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae
18. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid